Whereas it is estimated that more than 90,000 Americans will be diagnosed with a primary brain tumor in 2024, and an estimated 94,390 individuals in the United States were diagnosed with a primary brain tumor in 2023; Whereas it is estimated that more than 1,000,000 Americans are living with a brain tumor in the United States; Whereas, in the United States, brain tumors are the— (1) leading cause of death from cancer in children who are under 14 years of age and teens who are under 19 years of age; and (2) second-leading cause of death from cancer in young adults who are between 15 and 39 years of age; Whereas the average 5-year survival rate for an individual in the United States following the diagnosis of a primary malignant brain tumor is only 35.7 percent; Whereas it is estimated that 18,870 individuals in the United States will die as a result of a malignant brain tumor in 2024; Whereas brain tumors may be malignant or benign but can be life-threatening in either case; Whereas treatment of brain tumors is complicated by the fact that more than 100 types of brain tumors exist; Whereas the treatment and removal of brain tumors present significant challenges due to the uniquely complex and fragile nature of the brain; Whereas brain tumors affect the primary organ in the human body that controls not only cognitive ability but the actions of every other organ and limb in the body, leading to brain tumors being described as a disease that affects the whole individual; Whereas brain tumor research is supported by several private, nonprofit research foundations and by Federal medical research institutions; Whereas basic research may fuel advancements and the development of new treatments for brain tumors; Whereas obstacles to the development of new treatments for brain tumors remain, and there are limited strategies for the screening or early detection of brain tumors